Predictive factors of cytotoxic damage in radioactive iodine treatment of differentiated thyroid cancer patients.

Abstract

Radioactive iodine (131I) therapy in patients suffering from differentiated thyroid cancer (DTC) is a targeted treatment commonly used for thyroid ablation and locoregional and distant metastatic spread management. Despite a significant proportion of the 131I dose entering the circulation, there is currently no detailed information regarding its effect on… (More)

Topics

  • Presentations referencing similar topics